Change of Adviser
11 February 2008
Lipoxen plc
Change of Adviser
London, UK, 11 February, 2008 - Lipoxen PLC (AIM: LPX) a bio-pharmaceutical company specialising in the development of high value differentiated biologicals, vaccines and oncology drugs, today announces the appointment of Landsbanki Securities (UK) Limited as Nominated Adviser and Broker to the company with immediate effect.
| Enquiries: |
|
Lipoxen plc
M. Scott Maguire, Chief Executive Officer
Colin Hill, Finance Director |
+44 (0)20 7691 3583 |
Landsbanki Securities (UK) Limited
Shaun Dobson
Claes Spång |
+44 (0)20 7426 9000 |
Citigate Dewe Rogerson
David Dible
Emma Palmer |
+44 (0)20 7638 9571 |